Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Aug;32(8):1958–1962. doi: 10.1128/jcm.32.8.1958-1962.1994

Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans.

P D Mitchell 1, K D Reed 1, T L Aspeslet 1, M F Vandermause 1, J W Melski 1
PMCID: PMC263910  PMID: 7989549

Abstract

In view of the significant sequelae associated with Lyme borreliosis, there is a need for timely and accurate diagnosis of erythema migrans (EM). Although Borrelia burgdorferi can be cultured from biopsies of EM lesions, immunodiagnostic testing is more widely available. Four immunoserologic methods were studied by using the sera of 51 patients with EM lesions that were culture positive for B. burgdorferi. Nineteen patients had single primary lesions, and thirty-two had multiple secondary lesions. At the time of biopsy, 40 patients, 8 with primary lesions and all patients with secondary lesions, were seropositive by an immunoglobulin M (IgM) indirect fluorescent-antibody (IgM IFA) test (Bion Enterprises). Twenty-three patients were seropositive by a whole-cell fluorescence enzyme immunoassay (EIA) (BioWhittaker, Inc.), twenty-two were positive by immunoblotting (ViroStat, Inc.), and one was positive by a P39 recombinant EIA (P39 EIA) (General Biometrics, Inc.). Sera from various patient control groups were tested: rheumatoid arthritis (n = 19), infectious mononucleosis (n = 20), systemic lupus (n = 22), syphilis (n = 13), streptococcal sequelae (n = 20), and healthy subjects (n = 16). None of these sera reacted with the IgM IFA test or P39 EIA. Fifteen reacted with the fluorescence EIA. We conclude that the IgM IFA test is an effective and reliable assay for the diagnosis of EM, particularly for patients with secondary lesions. Immunoblot, fluorescence EIA, and P39 EIA lack the sensitivity to reliably diagnose EM.

Full text

PDF
1958

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguero-Rosenfeld M. E., Nowakowski J., McKenna D. F., Carbonaro C. A., Wormser G. P. Serodiagnosis in early Lyme disease. J Clin Microbiol. 1993 Dec;31(12):3090–3095. doi: 10.1128/jcm.31.12.3090-3095.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asbrink E. Cutaneous manifestations of Lyme borreliosis. Clinical definitions and differential diagnoses. Scand J Infect Dis Suppl. 1991;77:44–50. [PubMed] [Google Scholar]
  3. Bakken L. L., Case K. L., Callister S. M., Bourdeau N. J., Schell R. F. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA. 1992 Aug 19;268(7):891–895. [PubMed] [Google Scholar]
  4. Barbour A. G. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev. 1988 Oct;1(4):399–414. doi: 10.1128/cmr.1.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berardi V. P., Weeks K. E., Steere A. C. Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. J Infect Dis. 1988 Oct;158(4):754–760. doi: 10.1093/infdis/158.4.754. [DOI] [PubMed] [Google Scholar]
  6. Berger B. W. Dermatologic manifestations of Lyme disease. Rev Infect Dis. 1989 Sep-Oct;11 (Suppl 6):S1475–S1481. doi: 10.1093/clinids/11.supplement_6.s1475. [DOI] [PubMed] [Google Scholar]
  7. Berger B. W., Johnson R. C., Kodner C., Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol. 1992 Feb;30(2):359–361. doi: 10.1128/jcm.30.2.359-361.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Berger B. W., Kaplan M. H., Rothenberg I. R., Barbour A. G. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol. 1985 Sep;13(3):444–449. doi: 10.1016/s0190-9622(85)70187-9. [DOI] [PubMed] [Google Scholar]
  9. Berger B. W., Lesser R. L. Lyme disease. Dermatol Clin. 1992 Oct;10(4):763–775. [PubMed] [Google Scholar]
  10. Burgdorfer W., Barbour A. G., Hayes S. F., Benach J. L., Grunwaldt E., Davis J. P. Lyme disease-a tick-borne spirochetosis? Science. 1982 Jun 18;216(4552):1317–1319. doi: 10.1126/science.7043737. [DOI] [PubMed] [Google Scholar]
  11. Coleman J. L., Benach J. L. Characterization of antigenic determinants of Borrelia burgdorferi shared by other bacteria. J Infect Dis. 1992 Apr;165(4):658–666. doi: 10.1093/infdis/165.4.658. [DOI] [PubMed] [Google Scholar]
  12. Cutler S. J., Wright D. J. Evaluation of three commercial tests for Lyme disease. Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):271–272. doi: 10.1016/0732-8893(90)90072-4. [DOI] [PubMed] [Google Scholar]
  13. Dammin G. J. Erythema migrans: a chronicle. Rev Infect Dis. 1989 Jan-Feb;11(1):142–151. doi: 10.1093/clinids/11.1.142. [DOI] [PubMed] [Google Scholar]
  14. Dressler F., Whalen J. A., Reinhardt B. N., Steere A. C. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993 Feb;167(2):392–400. doi: 10.1093/infdis/167.2.392. [DOI] [PubMed] [Google Scholar]
  15. Fawcett P. T., Gibney K. M., Rose C. D., Dubbs S. B., Doughty R. A. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens. J Rheumatol. 1992 Apr;19(4):582–587. [PubMed] [Google Scholar]
  16. Fawcett P. T., Gibney K. M., Rose C. D., Klein J. D., Doughty R. A. Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease. J Rheumatol. 1991 May;18(5):705–708. [PubMed] [Google Scholar]
  17. Fawcett P. T., O'Brien A. E., Doughty R. A. An adsorption procedure to increase the specificity of enzyme-linked immunosorbent assays for Lyme disease without decreasing sensitivity. Arthritis Rheum. 1989 Aug;32(8):1041–1044. doi: 10.1002/anr.1780320814. [DOI] [PubMed] [Google Scholar]
  18. Fawcett P. T., Rose C., Gibney K. M., Chase C. A., Kiehl B., Doughty R. A. Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting. J Rheumatol. 1993 Apr;20(4):734–738. [PubMed] [Google Scholar]
  19. Feder H. M., Jr, Gerber M. A., Krause P. J., Ryan R., Shapiro E. D. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics. 1993 Feb;91(2):456–459. [PubMed] [Google Scholar]
  20. Fister R. D., Weymouth L. A., McLaughlin J. C., Ryan R. W., Tilton R. C. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J Clin Microbiol. 1989 Dec;27(12):2834–2837. doi: 10.1128/jcm.27.12.2834-2837.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Grodzicki R. L., Steere A. C. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis. 1988 Apr;157(4):790–797. doi: 10.1093/infdis/157.4.790. [DOI] [PubMed] [Google Scholar]
  22. Hansen K., Asbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Microbiol. 1989 Mar;27(3):545–551. doi: 10.1128/jcm.27.3.545-551.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Karlsson M. Western immunoblot and flagellum enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol. 1990 Sep;28(9):2148–2150. doi: 10.1128/jcm.28.9.2148-2150.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lange R., Bocklage H., Schneider T., Kölmel H. W., Heesemann J., Karch H. Ovalbumin blocking improves sensitivity and specificity of immunoglobulin M immunoblotting for serodiagnosis of patients with erythema migrans. J Clin Microbiol. 1992 Jan;30(1):229–232. doi: 10.1128/jcm.30.1.229-232.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ma B., Christen B., Leung D., Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol. 1992 Feb;30(2):370–376. doi: 10.1128/jcm.30.2.370-376.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Magnarelli L. A., Fikrig E., Berland R., Anderson J. F., Flavell R. A. Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol. 1992 Dec;30(12):3158–3162. doi: 10.1128/jcm.30.12.3158-3162.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Magnarelli L. A. Laboratory diagnosis of Lyme disease. Rheum Dis Clin North Am. 1989 Nov;15(4):735–745. [PubMed] [Google Scholar]
  28. Magnarelli L. A., Meegan J. M., Anderson J. F., Chappell W. A. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol. 1984 Aug;20(2):181–184. doi: 10.1128/jcm.20.2.181-184.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Malane M. S., Grant-Kels J. M., Feder H. M., Jr, Luger S. W. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med. 1991 Mar 15;114(6):490–498. doi: 10.7326/0003-4819-114-6-490. [DOI] [PubMed] [Google Scholar]
  30. Melski J. W., Reed K. D., Mitchell P. D., Barth G. D. Primary and secondary erythema migrans in central Wisconsin. Arch Dermatol. 1993 Jun;129(6):709–716. [PubMed] [Google Scholar]
  31. Mitchell P. D., Reed K. D., Vandermause M. F., Melski J. W. Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans. Am J Clin Pathol. 1993 Jan;99(1):104–107. doi: 10.1093/ajcp/99.1.104. [DOI] [PubMed] [Google Scholar]
  32. Olsson I., von Stedingk L. V., Hanson H. S., von Stedingk M., Asbrink E., Hovmark A. Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans. Acta Derm Venereol. 1991;71(2):127–133. [PubMed] [Google Scholar]
  33. Paparone P. W., Paparone P. A. Variable cutaneous manifestations of Lyme disease. N J Med. 1993 Mar;90(3):200–204. [PubMed] [Google Scholar]
  34. Rose C. D., Fawcett P. T., Singsen B. H., Dubbs S. B., Doughty R. A. Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease. Pediatrics. 1991 Sep;88(3):465–470. [PubMed] [Google Scholar]
  35. Russell H., Sampson J. S., Schmid G. P., Wilkinson H. W., Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis. 1984 Mar;149(3):465–470. doi: 10.1093/infdis/149.3.465. [DOI] [PubMed] [Google Scholar]
  36. Sayahtaheri-Altaie S., Meier F. A., Dalton H. P. Identification of species-specific, non-cross-reactive proteins of Borrelia burgdorferi. Diagn Microbiol Infect Dis. 1993 Jan;16(1):43–51. doi: 10.1016/0732-8893(93)90129-u. [DOI] [PubMed] [Google Scholar]
  37. Schmitz J. L., Powell C. S., Folds J. D. Comparison of seven commercial kits for detection of antibodies to Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):419–424. doi: 10.1007/BF01967435. [DOI] [PubMed] [Google Scholar]
  38. Schwan T. G., Schrumpf M. E., Gage K. L., Gilmore R. D., Jr Analysis of Leptospira spp., Leptonema illini, and Rickettsia rickettsii for the 39-kilodalton antigen (P39) of Borrelia burgdorferi. J Clin Microbiol. 1992 Mar;30(3):735–738. doi: 10.1128/jcm.30.3.735-738.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schwartz I., Wormser G. P., Schwartz J. J., Cooper D., Weissensee P., Gazumyan A., Zimmermann E., Goldberg N. S., Bittker S., Campbell G. L. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol. 1992 Dec;30(12):3082–3088. doi: 10.1128/jcm.30.12.3082-3088.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Scrimenti R. J. Erythema chronicum migrans. Arch Dermatol. 1970 Jul;102(1):104–105. [PubMed] [Google Scholar]
  41. Sigal L. H. Lyme disease: a world-wide borreliosis. Clin Exp Rheumatol. 1988 Oct-Dec;6(4):411–421. [PubMed] [Google Scholar]
  42. Simpson W. J., Schrumpf M. E., Schwan T. G. Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol. 1990 Jun;28(6):1329–1337. doi: 10.1128/jcm.28.6.1329-1337.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Steere A. C., Grodzicki R. L., Kornblatt A. N., Craft J. E., Barbour A. G., Burgdorfer W., Schmid G. P., Johnson E., Malawista S. E. The spirochetal etiology of Lyme disease. N Engl J Med. 1983 Mar 31;308(13):733–740. doi: 10.1056/NEJM198303313081301. [DOI] [PubMed] [Google Scholar]
  44. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  45. Steere A. C., Malawista S. E., Hardin J. A., Ruddy S., Askenase W., Andiman W. A. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977 Jun;86(6):685–698. doi: 10.7326/0003-4819-86-6-685. [DOI] [PubMed] [Google Scholar]
  46. Wormser G. P., Forseter G., Cooper D., Nowakowski J., Nadelman R. B., Horowitz H., Schwartz I., Bowen S. L., Campbell G. L., Goldberg N. S. Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. JAMA. 1992 Sep 9;268(10):1311–1313. [PubMed] [Google Scholar]
  47. Zöller L., Burkard S., Schäfer H. Validity of western immunoblot band patterns in the serodiagnosis of Lyme borreliosis. J Clin Microbiol. 1991 Jan;29(1):174–182. doi: 10.1128/jcm.29.1.174-182.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Zöller L., Cremer J., Faulde M. Western blot as a tool in the diagnosis of Lyme borreliosis. Electrophoresis. 1993 Sep;14(9):937–944. doi: 10.1002/elps.11501401149. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES